These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 16380634)

  • 1. Modafinil for fatigue in MS: a randomized placebo-controlled double-blind study.
    Kraft GH; Bowen J
    Neurology; 2005 Dec; 65(12):1995-7; author reply 1995-7. PubMed ID: 16380634
    [No Abstract]   [Full Text] [Related]  

  • 2. Modafinil for fatigue in MS: a randomized placebo-controlled double-blind study.
    Rammohan KW; Lynn DJ
    Neurology; 2005 Dec; 65(12):1995-7; author reply 1995-7. PubMed ID: 16382509
    [No Abstract]   [Full Text] [Related]  

  • 3. Modafinil for fatigue in MS: a randomized placebo-controlled double-blind study.
    Stankoff B; Waubant E; Confavreux C; Edan G; Debouverie M; Rumbach L; Moreau T; Pelletier J; Lubetzki C; Clanet M;
    Neurology; 2005 Apr; 64(7):1139-43. PubMed ID: 15824337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modafinil for Parkinson's disease fatigue.
    Tyne HL; Taylor J; Baker GA; Steiger MJ
    J Neurol; 2010 Mar; 257(3):452-6. PubMed ID: 19842011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modafinil improves symptoms of attention-deficit/hyperactivity disorder across subtypes in children and adolescents.
    Biederman J; Pliszka SR
    J Pediatr; 2008 Mar; 152(3):394-9. PubMed ID: 18280848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normalizing effects of modafinil on cocaine-induced sleep abnormalities.
    Dackis C; O'Brien CP
    Am J Psychiatry; 2010 Mar; 167(3):248-9. PubMed ID: 20194486
    [No Abstract]   [Full Text] [Related]  

  • 7. On chronic fatigue syndrome.
    Bobo WV; Hall WC
    Am J Psychiatry; 2004 Jun; 161(6):1132-3; author reply 1133-4. PubMed ID: 15169716
    [No Abstract]   [Full Text] [Related]  

  • 8. Placebo and modafinil effect on sleepiness in obstructive sleep apnea.
    Bittencourt LR; Lucchesi LM; Rueda AD; Garbuio SA; Palombini LO; Guilleminault C; Tufik S
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):552-9. PubMed ID: 18053628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modafinil is not the new caffeine.
    Dasheiff RM
    Neurology; 2010 Nov; 75(20):1764-5. PubMed ID: 21079178
    [No Abstract]   [Full Text] [Related]  

  • 10. ["Fatigue" in multiple sclerosis].
    Hohlfeld R
    Nervenarzt; 2000 Aug; 71(8):686. PubMed ID: 10996922
    [No Abstract]   [Full Text] [Related]  

  • 11. Modafinil for the treatment of daytime sleepiness in Parkinson's disease: a double-blind, randomized, crossover, placebo-controlled polygraphic trial.
    Högl B; Saletu M; Brandauer E; Glatzl S; Frauscher B; Seppi K; Ulmer H; Wenning G; Poewe W
    Sleep; 2002 Dec; 25(8):905-9. PubMed ID: 12489899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized trial of modafinil for the treatment of fatigue and excessive daytime sleepiness in individuals with chronic traumatic brain injury.
    Jha A; Weintraub A; Allshouse A; Morey C; Cusick C; Kittelson J; Harrison-Felix C; Whiteneck G; Gerber D
    J Head Trauma Rehabil; 2008; 23(1):52-63. PubMed ID: 18219235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of a deficit of arousal with fatigue in multiple sclerosis: effect of modafinil.
    Niepel G; Bibani RH; Vilisaar J; Langley RW; Bradshaw CM; Szabadi E; Constantinescu CS
    Neuropharmacology; 2013 Jan; 64():380-8. PubMed ID: 22766394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatigue in multiple sclerosis.
    Krupp LB; Christodoulou C
    Curr Neurol Neurosci Rep; 2001 May; 1(3):294-8. PubMed ID: 11898532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modafinil for atypical depression: effects of open-label and double-blind discontinuation treatment.
    Vaishnavi S; Gadde K; Alamy S; Zhang W; Connor K; Davidson JR
    J Clin Psychopharmacol; 2006 Aug; 26(4):373-8. PubMed ID: 16855454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modafinil in treatment of fatigue in multiple sclerosis. Results of an open-label study.
    Zifko UA; Rupp M; Schwarz S; Zipko HT; Maida EM
    J Neurol; 2002 Aug; 249(8):983-7. PubMed ID: 12195441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modafinil augmentation of selective serotonin reuptake inhibitor therapy in MDD partial responders with persistent fatigue and sleepiness.
    Fava M; Thase ME; DeBattista C; Doghramji K; Arora S; Hughes RJ
    Ann Clin Psychiatry; 2007; 19(3):153-9. PubMed ID: 17729016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of modafinil on subjective fatigue in multiple sclerosis and stroke patients.
    Brioschi A; Gramigna S; Werth E; Staub F; Ruffieux C; Bassetti C; Schluep M; Annoni JM
    Eur Neurol; 2009; 62(4):243-9. PubMed ID: 19672078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treating fatigue in patients with MS: one step forward, one step back.
    Schwid SR; Murray TJ
    Neurology; 2005 Apr; 64(7):1111-2. PubMed ID: 15824329
    [No Abstract]   [Full Text] [Related]  

  • 20. Pain affects depression through anxiety, fatigue, and sleep in multiple sclerosis.
    Amtmann D; Askew RL; Kim J; Chung H; Ehde DM; Bombardier CH; Kraft GH; Jones SM; Johnson KL
    Rehabil Psychol; 2015 Feb; 60(1):81-90. PubMed ID: 25602361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.